UPLOAD Filing
NextCure, Inc.
Date: July 24, 2025 · CIK: 0001661059 · Accession: 0000000000-25-007812
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288763
Letter
Re: NextCure, Inc. Registration Statement on Form S-3 Filed July 18, 2025 File No. 333-288763 Dear Michael Richman:
July 24, 2025
Michael Richman Chief Executive Officer NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville, Maryland 20705
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Kostian Ciko, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 24, 2025 Michael Richman Chief Executive Officer NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville, Maryland 20705 Re: NextCure, Inc. Registration Statement on Form S-3 Filed July 18, 2025 File No. 333-288763 Dear Michael Richman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kostian Ciko, Esq. </TEXT> </DOCUMENT>